Stockreport

Annovis Bio Reports Second Quarter Financial Results and Provides Business Update

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developin [Read more]